In addition, the genetic panel shared by all participating centers was initially limited to screening SOD1, C9orf72, TARDBP, and FUS mutations, and was extended to other ALS- or FTD-related mutations only in familial cases. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.